Biz YZGÜCÜ BİST HS Ekranı Takip Portföy BES Kazan Haber Araçlar Premium Sabitler Temettüler Blog Ekip Giriş
BIST HubPharmaceuticals › GENIL Research
BIST: GENIL
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.
BIST Star
BuybackHalalAnkara
Compare
9.26 TRY
Source: KAP
Market Cap
TRY41,670,000,000 TRY
USD$922,576,217
EUR
1 USD = 45.17 TRY
Current Snapshot - 2025 Q4
P/E Ratio
22.03x
↓ vs prior period
P/B Ratio
4.03x
↓ vs prior period
Gross Margin
20.97%
Op. Margin
9.86%
↓ vs prior period
Net Margin
9.86%
↑ vs prior period
ROE
18.30%
↑ vs prior period
ROA
9.73%
Source: KAP
Debt / Equity
0.88x
↑ vs prior period
Current Ratio
1.27x
Liquidity check
Equity Ratio
53.14%
Asset coverage
EV / EBIT
22.03x
↓ vs prior period
Op. profit proxy
EV / Sales
2.17x
↓ vs prior period
Enterprise value
Piotroski F
4/9
Neutral (4/9)
Altman Z-Score
4.92
↑ vs prior period
Safe Zone ✓
Sector Benchmarks KGK — Tümü · 11,069 companies · FY2023 (latest available)
Sector ROE22.0%
Net Margin10.0%
Current Ratio1.17x
Debt/Equity0.73x
Earnings — Q4 2025
Net Income YoY (vs Q4 2024)
▲ +73.3%
1.9B TRY vs 1.1B TRY
Revenue YoY (vs Q4 2024)
▲ +30.1%
19.2B TRY vs 14.7B TRY
Net Income QoQ (vs Q3 2025)
▲ +25.0%
1.9B TRY vs 1.5B TRY
Revenue QoQ (vs Q3 2025)
▲ +33.6%
19.2B TRY vs 14.4B TRY
Latest KAP Filings
Loading filings...
▼ SELL Abidin Gülmüş · ₺10.20 · 2026-04-15 KAP ↗
+ 15 more transactionsPremium only
Sector Peers
View all in sector →
SELECSELÇUK ECZA DEPOSU TİCARET VE P/E 31.2ROE 6.9%64.6B ECILCEİS ECZACIBAŞI İLAÇ SINAİ VE FP/E 82.6ROE 1.2%58.6B DEVADEVA HOLDİNG A.Ş.P/E 17.4ROE 2.9%13.2B TRILCTURK İLAÇ VE SERUM SANAYİ A.Ş.P/E 3.0ROE 16.3%3.8B